- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03384628
An Evaluation Of The Fitting Success Rate Of Senofilcon A Soft Contact Lenses In Three Designs.
June 6, 2018 updated by: Graeme Young
This study will compare the on-eye fitting characteristics of three types of contact lenses.
Each lens pair will be worn for 30 to 45 minutes before assessment and the results will be compared to mathematically calculated fitting characteristics.
Study Overview
Status
Completed
Conditions
Detailed Description
This will be an approx.
40-60 subject, one-day, double-masked, randomised, repeated measures study.
Each subject will wear the three lens types bilaterally in random succession, a total of six lenses will therefore be worn by each subject (3 per eye).
Study Type
Interventional
Enrollment (Actual)
51
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Surrey
-
Farnham, Surrey, United Kingdom, GU9 7EN
- Visioncare research
-
-
West Midlands
-
Birmingham, West Midlands, United Kingdom, B4 7ET
- Aston University Optometry Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 18-70 years.
- Able to read, comprehend and sign an informed consent.
- Willing to comply with the wear and study assessment schedule.
- Spherical distance prescription between -0.50 and -6.00 (inc.).
- Astigmatism, if present,≤1.50DC in both eyes.
- Have normal eyes with no evidence of any ocular abnormality or disease. For the purposes of this study a normal eye is defined as one having:
A clear central cornea. No anterior segment disorders. No clinically significant slit lamp findings (i.e. corneal oedema, significant staining, central scarring, infiltrates, active neovascularisation). No other active ocular disease (including pterygia).
Exclusion Criteria:
- Previous anterior ocular surgery
Any active corneal infection, injury or inflammation
. •Large pinguecula likely to affect soft lens fit
- Systemic or ocular disease or medication which might interfere with CL wear
- Pregnancy or breastfeeding
- Participation in any concurrent trial
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: First Pair Senofilcon A contact lens
The first pair of Senofilcon A contact lenses is applied (according to the fitting schedule), allowed to settle before assessment of the first pair Senofilcon A contact lens and subsequent removal.
|
Fit assessment of the first pair contact lenses.
|
Active Comparator: Second pair Senofilcon A contact lens
The second pair of contact lenses is applied (according to the fitting schedule), allowed to settle before assessment of the second pair Senofilcon A contact lens and subsequent removal.
|
Fit assessment of the second pair of contact lenses.
|
Active Comparator: Third pair Senofilcon A contact lens
The third pair of Senofilcon A contact lens is applied (according to the fitting schedule), allowed to settle before assessment of the third pair Senofilcon A contact lens and subsequent removal.
|
Fit assessment of the third pair of contact lenses.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lens fit (position on the eye) in mm
Time Frame: 25 minutes
|
Horizontal Lens Centration (mm), Vertical Lens Centration (mm), Post-blink movement in primary gaze (mm), Version lag (mm), Horizontal corneal overlap (mm), Diameter acceptance (mm),
|
25 minutes
|
Lens edge tightness fit grade 0-4
Time Frame: 5 minutes
|
Edge tightness (grade 0-4)
|
5 minutes
|
Lens tightness fit graded as %
Time Frame: 5 minutes
|
Tightness (push-up %),
|
5 minutes
|
Lens overall fit grade 0-5
Time Frame: 5 minutes
|
Overall fit acceptability (Grade 0-5),
|
5 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Graeme Young, PhD MPhil, Managing director
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 26, 2018
Primary Completion (Actual)
May 24, 2018
Study Completion (Actual)
May 24, 2018
Study Registration Dates
First Submitted
December 8, 2017
First Submitted That Met QC Criteria
December 19, 2017
First Posted (Actual)
December 27, 2017
Study Record Updates
Last Update Posted (Actual)
June 7, 2018
Last Update Submitted That Met QC Criteria
June 6, 2018
Last Verified
April 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- TRTN-501
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
He Eye HospitalNot yet recruiting
-
University of BradfordCoopervision, Inc.; University of HuddersfieldNot yet recruiting
-
Visioneering Technologies, IncRecruitingMyopiaUnited States, Canada, Hong Kong, Singapore
-
University Eye Hospital, FreiburgRecruiting
-
Shanghai 10th People's HospitalCompletedMyopia | Myopia, ProgressiveChina
-
Tianjin Eye HospitalActive, not recruiting
-
Tianjin Eye HospitalCompleted
-
Sultan Qaboos UniversityChristian Medical College, Vellore, IndiaUnknown
-
Peking University People's HospitalUnknownProgressive MyopiaChina
-
Shanghai Eye Disease Prevention and Treatment CenterNot yet recruiting
Clinical Trials on First pair Senofilcon A contact lens
-
Johnson & Johnson Vision Care, Inc.Completed
-
Coopervision, Inc.CORERecruiting
-
Coopervision, Inc.CORECompletedMyopiaUnited States, Canada
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedAstigmatismAustralia, United States
-
University of Illinois at ChicagoJohnson & Johnson Vision Care, Inc.UnknownModerate to Severe Dry Eye DiseaseUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Johnson & JohnsonTerminatedRefractive Error | Astigmatism | MyopiaJapan